Selected research
Industry Research
Topical Hemostatic Agents Industry Research Report 2026
Market perspective
The global Topical Hemostatic Agents market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Topical Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Topical Hemostatic Agents is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Topical Hemostatic Agents is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Topical Hemostatic Agents include Pfizer, B Braun Melsungen, Baxter International, Vascular Solutions, The Medicines Company, Marine Polymer Technologies, Integra LifeSciences, Gelita Medical and Ethicon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Topical Hemostatic Agents market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Topical Hemostatic Agents Market by Company
Pfizer
B Braun Melsungen
Baxter International
Vascular Solutions
The Medicines Company
Marine Polymer Technologies
Integra LifeSciences
Gelita Medical
Ethicon
Equimedical
C. R. Bard
Anika Therapeutics
Advanced Medical Solutions
Topical Hemostatic Agents Segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Topical Hemostatic Agents Segment by Application
Hospitals
Nursing Homes
Surgical Centers
Topical Hemostatic Agents Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Hemostatic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Topical Hemostatic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Hemostatic Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Topical Hemostatic Agents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Topical Hemostatic Agents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Topical Hemostatic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gelation Sponge
- Oxidized Regenerated Cellulose Based Hemostats
- Others
Applications
- Hospitals
- Nursing Homes
- Surgical Centers
Companies covered
- Pfizer
- B Braun Melsungen
- Baxter International
- Vascular Solutions
- The Medicines Company
- Marine Polymer Technologies
- Integra LifeSciences
- Gelita Medical
- Ethicon
- Equimedical
- C. R. Bard
- Anika Therapeutics
- Advanced Medical Solutions
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Topical Hemostatic Agents Market Size (2021-2032)
- 2.2.2 Global Topical Hemostatic Agents Sales (2021-2032)
- 2.2.3 Global Topical Hemostatic Agents Market Average Price (2021-2032)
- 2.3 Topical Hemostatic Agents by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Gelation Sponge
- 2.3.3 Oxidized Regenerated Cellulose Based Hemostats
- 2.3.4 Others
- 2.4 Topical Hemostatic Agents by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Nursing Homes
- 2.4.4 Surgical Centers
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Topical Hemostatic Agents Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Topical Hemostatic Agents Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Topical Hemostatic Agents Revenue of Manufacturers (2021-2026)
- 3.4 Global Topical Hemostatic Agents Average Price by Manufacturers (2021-2026)
- 3.5 Global Topical Hemostatic Agents Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Topical Hemostatic Agents, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Topical Hemostatic Agents, Product Type & Application
- 3.8 Global Manufacturers of Topical Hemostatic Agents, Established Date
- 3.9 Global Topical Hemostatic Agents Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pfizer
- 4.1.1 Pfizer Company Information
- 4.1.2 Pfizer Business Overview
- 4.1.3 Pfizer Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pfizer Topical Hemostatic Agents Product Portfolio
- 4.1.5 Pfizer Recent Developments
- 4.2 B Braun Melsungen
- 4.2.1 B Braun Melsungen Company Information
- 4.2.2 B Braun Melsungen Business Overview
- 4.2.3 B Braun Melsungen Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 B Braun Melsungen Topical Hemostatic Agents Product Portfolio
- 4.2.5 B Braun Melsungen Recent Developments
- 4.3 Baxter International
- 4.3.1 Baxter International Company Information
- 4.3.2 Baxter International Business Overview
- 4.3.3 Baxter International Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Baxter International Topical Hemostatic Agents Product Portfolio
- 4.3.5 Baxter International Recent Developments
- 4.4 Vascular Solutions
- 4.4.1 Vascular Solutions Company Information
- 4.4.2 Vascular Solutions Business Overview
- 4.4.3 Vascular Solutions Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Vascular Solutions Topical Hemostatic Agents Product Portfolio
- 4.4.5 Vascular Solutions Recent Developments
- 4.5 The Medicines Company
- 4.5.1 The Medicines Company Company Information
- 4.5.2 The Medicines Company Business Overview
- 4.5.3 The Medicines Company Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 The Medicines Company Topical Hemostatic Agents Product Portfolio
- 4.5.5 The Medicines Company Recent Developments
- 4.6 Marine Polymer Technologies
- 4.6.1 Marine Polymer Technologies Company Information
- 4.6.2 Marine Polymer Technologies Business Overview
- 4.6.3 Marine Polymer Technologies Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Marine Polymer Technologies Topical Hemostatic Agents Product Portfolio
- 4.6.5 Marine Polymer Technologies Recent Developments
- 4.7 Integra LifeSciences
- 4.7.1 Integra LifeSciences Company Information
- 4.7.2 Integra LifeSciences Business Overview
- 4.7.3 Integra LifeSciences Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Integra LifeSciences Topical Hemostatic Agents Product Portfolio
- 4.7.5 Integra LifeSciences Recent Developments
- 4.8 Gelita Medical
- 4.8.1 Gelita Medical Company Information
- 4.8.2 Gelita Medical Business Overview
- 4.8.3 Gelita Medical Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Gelita Medical Topical Hemostatic Agents Product Portfolio
- 4.8.5 Gelita Medical Recent Developments
- 4.9 Ethicon
- 4.9.1 Ethicon Company Information
- 4.9.2 Ethicon Business Overview
- 4.9.3 Ethicon Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Ethicon Topical Hemostatic Agents Product Portfolio
- 4.9.5 Ethicon Recent Developments
- 4.10 Equimedical
- 4.10.1 Equimedical Company Information
- 4.10.2 Equimedical Business Overview
- 4.10.3 Equimedical Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Equimedical Topical Hemostatic Agents Product Portfolio
- 4.10.5 Equimedical Recent Developments
- 4.11 C. R. Bard
- 4.11.1 C. R. Bard Company Information
- 4.11.2 C. R. Bard Business Overview
- 4.11.3 C. R. Bard Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 C. R. Bard Topical Hemostatic Agents Product Portfolio
- 4.11.5 C. R. Bard Recent Developments
- 4.12 Anika Therapeutics
- 4.12.1 Anika Therapeutics Company Information
- 4.12.2 Anika Therapeutics Business Overview
- 4.12.3 Anika Therapeutics Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Anika Therapeutics Topical Hemostatic Agents Product Portfolio
- 4.12.5 Anika Therapeutics Recent Developments
- 4.13 Advanced Medical Solutions
- 4.13.1 Advanced Medical Solutions Company Information
- 4.13.2 Advanced Medical Solutions Business Overview
- 4.13.3 Advanced Medical Solutions Topical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Advanced Medical Solutions Topical Hemostatic Agents Product Portfolio
- 4.13.5 Advanced Medical Solutions Recent Developments
5 Global Topical Hemostatic Agents Market Scenario by Region
- 5.1 Global Topical Hemostatic Agents Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Topical Hemostatic Agents Sales by Region: 2021-2032
- 5.2.1 Global Topical Hemostatic Agents Sales by Region: 2021-2026
- 5.2.2 Global Topical Hemostatic Agents Sales by Region: 2027-2032
- 5.3 Global Topical Hemostatic Agents Revenue by Region: 2021-2032
- 5.3.1 Global Topical Hemostatic Agents Revenue by Region: 2021-2026
- 5.3.2 Global Topical Hemostatic Agents Revenue by Region: 2027-2032
- 5.4 North America Topical Hemostatic Agents Market Facts & Figures by Country
- 5.4.1 North America Topical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Topical Hemostatic Agents Sales by Country (2021-2032)
- 5.4.3 North America Topical Hemostatic Agents Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Topical Hemostatic Agents Market Facts & Figures by Country
- 5.5.1 Europe Topical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Topical Hemostatic Agents Sales by Country (2021-2032)
- 5.5.3 Europe Topical Hemostatic Agents Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Topical Hemostatic Agents Market Facts & Figures by Country
- 5.6.1 Asia Pacific Topical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Topical Hemostatic Agents Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Topical Hemostatic Agents Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Topical Hemostatic Agents Market Facts & Figures by Country
- 5.7.1 South America Topical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Topical Hemostatic Agents Sales by Country (2021-2032)
- 5.7.3 South America Topical Hemostatic Agents Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Topical Hemostatic Agents Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Topical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Topical Hemostatic Agents Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Topical Hemostatic Agents Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Topical Hemostatic Agents Sales by Type (2021-2032)
- 6.1.1 Global Topical Hemostatic Agents Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Topical Hemostatic Agents Sales Market Share by Type (2021-2032)
- 6.2 Global Topical Hemostatic Agents Revenue by Type (2021-2032)
- 6.2.1 Global Topical Hemostatic Agents Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Topical Hemostatic Agents Revenue Market Share by Type (2021-2032)
- 6.3 Global Topical Hemostatic Agents Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Topical Hemostatic Agents Sales by Application (2021-2032)
- 7.1.1 Global Topical Hemostatic Agents Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Topical Hemostatic Agents Sales Market Share by Application (2021-2032)
- 7.2 Global Topical Hemostatic Agents Revenue by Application (2021-2032)
- 7.2.1 Global Topical Hemostatic Agents Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Topical Hemostatic Agents Revenue Market Share by Application (2021-2032)
- 7.3 Global Topical Hemostatic Agents Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Topical Hemostatic Agents Value Chain Analysis
- 8.1.1 Topical Hemostatic Agents Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Topical Hemostatic Agents Production Mode & Process
- 8.2 Topical Hemostatic Agents Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Topical Hemostatic Agents Distributors
- 8.2.3 Topical Hemostatic Agents Customers
9 Global Topical Hemostatic Agents Analyzing Market Dynamics
- 9.1 Topical Hemostatic Agents Industry Trends
- 9.2 Topical Hemostatic Agents Industry Drivers
- 9.3 Topical Hemostatic Agents Industry Opportunities and Challenges
- 9.4 Topical Hemostatic Agents Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst